Clinical Scorecard: Automated Bayesian Approach for Assessing the Degree and Distribution of Pulmonary Perfusion Alterations in CT Pulmonary Angiography for CTEPH

At a Glance

Key Highlights

• CTPA provides simultaneous assessment of pulmonary artery structure, parenchyma, and perfusion with diagnostic accuracy comparable to V/Q scans.
• Mosaic perfusion patterns on CTPA indicate peripheral small vessel disease and correlate with poor prognosis.
• An automated Bayesian method using Gaussian mixture modeling quantifies extent and distribution of perfusion changes on CTPA, reducing subjective variability.

Guideline-Based Recommendations

Diagnosis

• Use CTPA to evaluate pulmonary artery obstruction and perfusion defects in suspected CTEPH.
• Confirm diagnosis based on European Society of Cardiology criteria incorporating imaging and hemodynamic studies.

Management

• Perform comprehensive clinical and imaging assessment including V/Q scan, echocardiography, pulmonary function tests, and right heart catheterization.

Monitoring & Follow-up

• Assess perfusion heterogeneity and distribution using automated quantitative analysis on CTPA to monitor disease progression.

Risks

• Subjective interpretation of mosaic perfusion on CTPA can lead to variability; automated methods may reduce this risk.

Patient & Prescribing Data

Consecutive patients diagnosed with CTEPH in a tertiary referral center

Automated quantification of perfusion changes may assist in risk stratification and guide clinical decision-making.

Clinical Best Practices

• Utilize high-resolution CTPA with standardized acquisition protocols for optimal image quality.
• Incorporate automated Bayesian analysis tools to objectively quantify perfusion alterations and their spatial distribution.
• Combine imaging findings with clinical and hemodynamic data for comprehensive assessment of CTEPH.

References

• European Society of Cardiology Guidelines on CTEPH
• Total Segmentator Network on GitHub